⌘K

Login Start Free

Home/Filings/4/0001209191-23-052709

4//SEC Filing

Gall Matthew 4

Accession 0001209191-23-052709

CIK 0001808865other

View on SEC.gov Company Profile

Filed

Oct 11, 8:00 PM ET

Accepted

Oct 12, 5:09 PM ET

Size

4.6 KB

Accession

0001209191-23-052709

Insider Transaction Report

Form 4

Period: 2023-10-12

iTeos Therapeutics, Inc.ITOS

Chief Financial Officer

Transactions

Purchase
Common Stock
2023-10-12$8.37/sh+5,000$41,850→ 19,429 total

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

iTeos Therapeutics, Inc.

CIK 0001808865

Entity typeother

Related Parties

1

filerCIK 0001816194

Filing Metadata

Form type: 4
Filed: Oct 11, 8:00 PM ET
Accepted: Oct 12, 5:09 PM ET
Size: 4.6 KB

View on SEC.gov